Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Lower potential income exposure to charitable premium assistance program propels DaVita, shares ahead 4%

Published 10/16/2017, 10:04 AM
© Reuters.  Lower potential income exposure to charitable premium assistance program propels DaVita, shares ahead 4%
DVA
-
  • DaVita (DVA +4%) says if its charitable premium assistance program was eliminated, an unlikely scenario in its view, annual operating income would be trimmed $100M - 250M, assuming that most patients with commercial insurance would continue coverage, either with their current plan or a new one.
  • ~1,800 DaVita patients in the individual market segment receive charitable assistance. Most maintain their pre-end-stage renal disease (ESRD) coverage. The company says the majority would have access to premium tax credits and would be able to afford their premium without the charitable contribution. Nevertheless, it projects that annual operating income would be reduced by $45M - 90M if the program were discontinued.
  • In the commercial group segment, about 4,000 DaVits patients receive charitable premium assistance. About 55% are covered under employer-provided coverage and they receive charitable assistance to ease the financial burden of their co-pays, ~$200 - 300/month. The company believes most would continue coverage without the assistance.
  • The other 45% are on COBRA plans. The company believes many who could no longer afford the COBRA premium without financial help would qualify for and migrate to individual plans with premium tax credits, adding that a substantial portion would maintain coverage even without the assistance.
  • About 80% of the 19,000 DaVita patients in the government segment receive charitable premium assistance. The company believes that most would retain their Medicare coverage if the financial help was eliminated but they would likely lose their secondary (Medigap) coverage. It says the impact on operating income would be limited but there would be significant negative consequences for many patients.
  • Management will be prepared to answer additional questions during its Q3 earnings call.
  • Previously: DaVita discloses potential $450M exposure to operating income from charitable premium assistance (Oct. 10)
  • Now read: Providence Service Corporation: Underfollowed, Undervalued Medical Transportation Play


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.